148 related articles for article (PubMed ID: 16393439)
1. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study.
Bayly JR; Hollands RD; Riordan-Jones SE; Yemm SJ; Brough-Williams I; Thatcher M; Woodman NM; Dixon T
Curr Med Res Opin; 2006 Jan; 22(1):131-7. PubMed ID: 16393439
[TBL] [Abstract][Full Text] [Related]
2. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.
Hanley DA; Zhang Q; Meilleur MC; Mavros P; Sen SS
Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742
[TBL] [Abstract][Full Text] [Related]
3. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
Ringe JD; Faber H; Fahramand P; Schacht E
J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
[TBL] [Abstract][Full Text] [Related]
4. [Initial treatment trends in patient with osteoporosis: use of antiresorptive agents and pharmacologic supplements (calcium and vitamin D) in clinical practice].
Carbonell C; Díez A; Calaf J; Caloto MT; Nocea G; Lara N
Reumatol Clin; 2012; 8(1):3-9. PubMed ID: 22118802
[TBL] [Abstract][Full Text] [Related]
5. MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study.
Reymondier A; Caillet P; Abbas-Chorfa F; Ambrosi V; Jaglal SB; Chapurlat R; Schott AM
Osteoporos Int; 2013 Feb; 24(2):559-66. PubMed ID: 22588183
[TBL] [Abstract][Full Text] [Related]
6. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update.
Boonen S; Vanderschueren D; Haentjens P; Lips P
J Intern Med; 2006 Jun; 259(6):539-52. PubMed ID: 16704554
[TBL] [Abstract][Full Text] [Related]
7. [The role of vitamin D in the treatment of osteoporosis in the elderly].
Pfeifer M; Minne HW
Med Klin (Munich); 2006 Jun; 101 Suppl 1():15-9. PubMed ID: 16826364
[TBL] [Abstract][Full Text] [Related]
8. Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
Kennedy CC; Ioannidis G; Thabane L; Adachi JD; Marr S; Giangregorio LM; Morin SN; Crilly RG; Josse RG; Lohfeld L; Pickard LE; van der Horst ML; Campbell G; Stroud J; Dolovich L; Sawka AM; Jain R; Nash L; Papaioannou A
Trials; 2015 May; 16():214. PubMed ID: 25962885
[TBL] [Abstract][Full Text] [Related]
9. Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids.
Kohler MJ; Amezaga M; Drozd J; Crowley ST; Gulanski B; Anderson DR; Fraenkel L
J Gen Intern Med; 2013 Jun; 28(6):825-9. PubMed ID: 23404201
[TBL] [Abstract][Full Text] [Related]
10. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Gentilella R; Agnusdei D; Iori N; Nuti R;
J Bone Miner Res; 2006 Oct; 21(10):1565-70. PubMed ID: 16995811
[TBL] [Abstract][Full Text] [Related]
11. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
[TBL] [Abstract][Full Text] [Related]
12. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.
Vytrisalova M; Blazkova S; Palicka V; Vlcek J; Cejkova M; Hala T; Pavelka K; Koblihova H
Maturitas; 2008; 60(3-4):223-9. PubMed ID: 18774663
[TBL] [Abstract][Full Text] [Related]
13. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.
Resch H; Walliser J; Phillips S; Wehren LE; Sen SS
Curr Med Res Opin; 2007 Jun; 23(6):1227-37. PubMed ID: 17559732
[TBL] [Abstract][Full Text] [Related]
14. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K
Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493
[TBL] [Abstract][Full Text] [Related]
15. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
16. Reducing fracture risk with calcium and vitamin D.
Lips P; Bouillon R; van Schoor NM; Vanderschueren D; Verschueren S; Kuchuk N; Milisen K; Boonen S
Clin Endocrinol (Oxf); 2010 Sep; 73(3):277-85. PubMed ID: 20796001
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
Teschemaker A; Lee E; Xue Z; Wutoh AK
Am J Geriatr Pharmacother; 2008 Dec; 6(5):240-8. PubMed ID: 19161926
[TBL] [Abstract][Full Text] [Related]
19. Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture.
Talbot JC; Elener C; Praveen P; Shaw DL
Injury; 2007 Nov; 38(11):1236-40. PubMed ID: 17572417
[TBL] [Abstract][Full Text] [Related]
20. Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment.
Lanham-New SA
Proc Nutr Soc; 2008 May; 67(2):163-76. PubMed ID: 18412990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
